The DPP4 Inhibitors Market represents a vital segment within the worldwide diabetes pharmaceutical industry, marking a notable progression in type 2 diabetes treatment methodologies. These oral therapeutic compounds operate by suppressing the dipeptidyl peptidase-4 enzyme, thereby extending incretin hormone effectiveness that aids in maintaining blood glucose balance. As diabetes cases multiply...